Can antibody conjugated nanomicelles alter the prospect of antibody targeted therapy against schistosomiasis mansoni?
<h4>Background</h4>CLA (conjugated linoleic acid)-mediated activation of the schistosome tegument-associated sphingomyelinase and consequent disruption of the outer membrane might allow host antibodies to access the apical membrane antigens. Here, we investigated a novel approach to enha...
Saved in:
Main Authors: | Eglal I Amer (Author), Sonia R Allam (Author), Aceel Y Hassan (Author), Esmail M El-Fakharany (Author), Mona M Agwa (Author), Sherine N Khattab (Author), Eman Sheta (Author), Marwa H El-Faham (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Can antibody conjugated nanomicelles alter the prospect of antibody targeted therapy against schistosomiasis mansoni?
by: Eglal I. Amer, et al.
Published: (2023) -
Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens.
by: Marwa H El-Faham, et al.
Published: (2017) -
Antibody drug conjugates in the clinic
by: Edidiong Udofa, et al.
Published: (2024) -
Antibody-drug conjugates for cancer therapy
by: Anna Grzywa
Published: (2021) -
Antibody-Drug Conjugates: The Last Decade
by: Nicolas Joubert, et al.
Published: (2020)